Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Morgan Stanley starts coverage on a2 Milk Co stock, sees modest gains amid market headwinds

EditorAhmed Abdulazez Abdulkadir
Published 12/09/2024, 08:10 pm
ATM
-


On Thursday, Morgan Stanley (NYSE:MS) initiated coverage on a2 Milk Co (ATM:NZ) (OTC: ACOPF), assigning the stock an Equalweight rating and setting a price target of NZD6.40. The firm's analysis acknowledges a2 Milk's history of increasing market share and improving earnings quality. However, it also points to substantial challenges ahead, particularly in the China infant milk formula (IMF) market, which is undergoing significant changes and facing a low birthrate.


The firm's coverage notes the devaluation of a2 Milk's stock following its financial year 2024 results, which has led to a reset in valuation multiples. These adjusted multiples are now believed to reflect the risks inherent in a2 Milk's business. The firm's commentary suggests that these risks are well-understood and currently priced into the market.


The China IMF market, which is crucial for a2 Milk, is expected to continue deteriorating. Recent regulatory changes and the general market volatility have been putting pressure on average sales prices (ASP). Despite market consolidation, which typically favors established players by raising barriers to entry, the firm anticipates that gaining additional market share will become increasingly difficult for a2 Milk.


Morgan Stanley's position reflects a cautious outlook on a2 Milk's growth prospects, particularly in light of the challenging conditions in its key markets. The firm's analysis suggests that while a2 Milk has a solid track record, the future presents significant hurdles that cannot be overlooked.


The new price target of NZD6.40 is indicative of Morgan Stanley's assessment of a2 Milk's value in the current market context. The Equalweight rating implies that the firm views the company's stock as fairly valued at the time of the report, given the balance of potential risks and rewards.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.